Air Pollution and Cardiovascular Disease in Qatar: an Interventional Study to Reduce Blood Pressure

Recruiting N/A Interventional Study
Hypertension, Systolic Metabolic Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 60
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
100 (estimated)
Sponsor
Weill Cornell Medical College in Qatar · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The main objective is to determine if in-home portable air cleaners provide persistent reductions in PM2.5 exposures and improvements in systolic blood pressure and biochemical parameters over 4-weeks in patients with metabolic syndrome residing in Qatar.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Non-smokers (100% abstinence from use of any smoking or vaping product during the prior year) * Age ≥18 and less than 60 years old * Living in a single residence (home, apartment) located anywhere in Qatar * Mild systolic hypertension: screening visit systolic BP 130 to 159 mm…
Contacts

Charbel Abi Khalil, MD

+974 4492 8484

cha2022@qatar-med.cornell.edu

CONTACT